Europe Diabetes Care Devices Market

The Europe diabetes care devices market is expected to grow from US$ 8,371.49 million in 2022 to US$ 11,914.05 million by 2028; it is estimated to grow at a CAGR of 4.5% from 2022 to 2028.

Diabetes is a deadly chronic disease with no specialized cure. It is primarily caused by the body’s inability to produce or effectively use the hormone insulin. This inability prevents the body from adequately regulating blood glucose levels. There are two forms of diabetes—diabetes type-I or diabetes insipidus and diabetes type-2 or diabetes mellitus. There is a steady increase in the incidence of diabetes across Europe. Type 2 diabetes is the most prevalent type of diabetes and has increased with cultural and societal changes. In high-income countries, ~91% of adults have type 2 diabetes. As per the International Diabetes Federation (IDF), diabetes affected millions of persons aged 20-79 in 2021. Diabetes can lead to several complications in various body parts and raise the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are a few major complications associated with diabetes. Hence, patients suffering from this disease require frequent monitoring and external administration of insulin. The growing prevalence of diabetes is fueling the growth of the diabetes care devices market across the region.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe diabetes care devices market. The Europe diabetes care devices market is expected to grow at a good CAGR during the forecast period. 

Europe Diabetes Care Devices Market Revenue and Forecast to 2028 (US$ Million) 

Europe Diabetes Care Devices Market Segmentation        

The Europe diabetes care devices market is segmented based on type, end user, and country. Based on type, the market is bifurcated into glucose monitoring devices and insulin delivery devices. The glucose monitoring devices segment would dominate the market in 2022. The glucose monitoring devices segment is further divided into testing strips, glucometer, lancets, and others. Similarly, the insulin delivery devices segment is segmented into insulin pens, insulin syringes, insulin pumps, and others. Based on end user, the Europe diabetes care devices market is bifurcated into homecare and hospitals & clinics. The homecare segment would dominate the market in 2022. Based on country, the Europe diabetes care devices market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The Rest of Europe would dominate the market in 2022.

B. Braun Melsungen AG; BD; Dexcom, Inc.; Eli Lilly and Company.; F. Hoffmann-La Roche Ltd.; Insulet Corporation; Medtronic; Novo Nordisk A/S; Tandem Diabetes Care Inc.; and Terumo Corporation are among the leading companies in the Europe diabetes care devices market. 

Europe Diabetes Care Devices Market Strategic Insights

Europe Diabetes Care Devices Market Segmentation Analysis

Europe Diabetes Care Devices Market Report Highlights

Europe Diabetes Care Devices Report Scope

Europe Diabetes Care Devices Market Country and Regional Insights